<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Differentiated thyroid cancer":12,
"lenvatinib":8,
"tyrosine kinase inhibitor":6,
"oncology":5,
"papillary microcarcinoma":4,
"risk":1,
"thyroid cancer":72,
"treatment decision making":1,
"uncertainty":1,
"Costs and cost analysis":1,
"Diagnostic techniques and procedures":1,
"Thyroid neoplasms":16,
"Ultrasonography":12,
"Breast cancer screening":1,
"Breast ultrasound":1,
"Recall criteria":1,
"Ultrasonographic screening":1,
"Annexin A6":1,
"Bisphenol A":1,
"Endocrine disruptors":1,
"Maternal exposure":1,
"Proteomics":1,
"Valosin-containing protein":1,
"Women":2,
"Autoimmune diseases":2,
"Good's syndrome":1,
"Lupus systémique":1,
"Maladies auto-immunes":1,
"Polymyosite":1,
"Polymyositis":1,
"Syndrome de Good":1,
"Systemic lupus":1,
"Thymoma":2,
"Thymome":1,
"Adjuvant chemotherapy":1,
"Breast neoplasms":4,
"Cardiotoxicity":1,
"Dexrazoxane":1,
"Trastuzumab":1,
"APC mutation":1,
"Extracolonic cancer":1,
"FAP":1,
"Familial adenomatous polyposis":2,
"(131)I SPECT/TC":1,
"Carcinoma diferenciado de tiroides":1,
"Elastofibroma dorsi":1,
"False positive scan":1,
"Falso positivo scan":1,
"I-131 SPECT/CT":1,
"Radioiodine":4,
"Radioyodo":1,
"ALOPECIA":1,
"GLIOBLASTOMA MULTIFORME":1,
"HISTONE H3K9 DEMETHYLASE":1,
"JmjC DOMAIN":1,
"SOMATIC MUTATION":1,
"ARFI":1,
"Elastography":4,
"Parathyroid":4,
"Thyroid":43,
"Ultrasound":17,
"breast cancer":15,
"cancer susceptibility gene":1,
"microfluidic PCR":1,
"mutation":4,
"next-generation sequencing":2,
"core needle biopsy":2,
"diagnosis":6,
"neoplasm":3,
"pathology":3,
"thyroid nodule":21,
"active surveillance":3,
"medical cost":1,
"risk classification":1,
"surgery":7,
"unfavorable events":1,
"AKT":2,
"Oncogene-induced senescence":1,
"RET oncogene":1,
"epidemiology":6,
"hypothyroidism":3,
"thyroidectomy":16,
"thyroxin":1,
"interobserver variability":1,
"intraobserver variability":1,
"measurement":1,
"thyroid/parathyroid":6,
"AJCC staging":1,
"extrathyroidal extension":4,
"lymphovascular invasion":1,
"HIFU":1,
"thermal ablation":4,
"Bethesda":3,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":6,
"thyroid gland":7,
"thyroid neoplasm":9,
"Hashimoto's disease":1,
"lymph node dissection":2,
"lymph nodes":5,
"metastasis":18,
"outcomes assessment":1,
"prognostic factors":1,
"c-Met":1,
"cabozantinib":2,
"radiopharmaceutical":1,
"Computed tomography":2,
"Major salivary gland":1,
"Papillary thyroid carcinoma":42,
"Radioactive iodine ablation":3,
"Bethesda system":4,
"malignancy":9,
"risk of malignancy (ROM)":1,
"thyroid nodules":11,
"decision support":1,
"standardized reporting":1,
"Chernobyl":1,
"Fukushima":1,
"radiation exposure":2,
"thyroid surgery":3,
"ultrasound thyroid screening":1,
"Case report":1,
"endocrine gland":1,
"fluorodeoxyglucose positron emission tomography":1,
"small-cell lung carcinoma":1,
"American Thyroid Association":3,
"Children":3,
"Thyroid Image Reporting and Data System":1,
"Thyroid carcinoma":26,
"ATP synthase":1,
"ATP6":1,
"Cancer":22,
"Mitochondria":2,
"OM45":1,
"Permeability transition":1,
"18F-DOPA PET/CT":1,
"Medullary thyroid carcinoma":9,
"Prognostic value":1,
"Restaging":1,
"Cancer therapy":1,
"Clinical management":1,
"Diabetes":2,
"Diabetes therapy":1,
"Carcinoma, papillary":2,
"Neoplasm metastasis":4,
"Programmed death-ligand 1":2,
"BRAF mutation":5,
"noninvasive follicular variant of papillary thyroid carcinoma":1,
"pediatric thyroid lesions":1,
"Adenoma":3,
"MLH1":1,
"MSH2":1,
"MSH6":1,
"polyp":1,
"tumour":1,
"S-1":1,
"chemotherapy":5,
"cisplatin":1,
"unknown primary origin":1,
"over detection":1,
"calcitonin":3,
"elective neck dissection":1,
"observation":2,
"regional metastases":1,
"free iodide":1,
"iodide uptake":1,
"iodinated contrast media":1,
"salivary glands":2,
"Breast-conserving surgical procedures":1,
"CT contrast":1,
"Radioiodination":1,
"Radiopaque fiducial marker":1,
"biomarker":6,
"chromogranin A":1,
"neuroendocrine neoplasm":1,
"prognosis":14,
"response to treatment":1,
"BRAFV600E mutation":1,
"Central lymph node metastasis":1,
"Multifocality":1,
"Prophylactic lymph node dissection":2,
"fine needle aspiration cytology":4,
"hyperparathyroidism":3,
"parathyroid carcinoma":3,
"CD20":1,
"Immunohistochemistry":15,
"anaplastic carcinoma":1,
"cancer genome":1,
"follicular carcinoma":2,
"papillary carcinoma":8,
"Cell line":1,
"Lung adenocarcinoma":3,
"Micropapillary":1,
"Molecular":3,
"Papillary":4,
"American Joint Committee on Cancer (AJCC)":1,
"anaplastic":2,
"staging":2,
"Schwannoma":1,
"TTF-1":1,
"Transcriptional activation":1,
"mRNA":1,
"qPCR":1,
"oncogene testing":1,
"pediatric thyroid cancer":2,
"Bone metastases":3,
"Denosumab-radioiodine":1,
"Zoledronate":1,
"WhatsApp":1,
"cytopathology":1,
"smartphone":1,
"static image":1,
"telecytology":1,
"lymph node ratio":2,
"lymph node yield":1,
"nodal metastasis":2,
"recurrence":12,
"chyle leakage":1,
"conservative management":1,
"dietary modification":1,
"thoracic duct ligation":1,
"carcinoma":12,
"carcinoma showing thymus-like elements (CASTLE)":1,
"genetic analysis":1,
"parotid":1,
"thymus-like differentiation":1,
"Neck Dissection":5,
"Abscess":1,
"Drainage":1,
"Guideline":1,
"Metastases":2,
"Percutaneous ablation":1,
"Safety":1,
"Ultrasound guidance":1,
"maximum standardized uptake value (SUVmax)":1,
"positron emission tomography (PET)/CT":1,
"recurrent thyroid cancer":1,
"serum thyroglobulin (Tg)":1,
"thyroglobulin antibody (TgAb)":1,
"Kidney":1,
"Drug resistance mutant":1,
"Medullary thyroid cancer":6,
"RET kinase":1,
"Structure-activity relationship":1,
"endocrine cancers":1,
"rare diseases/syndromes":1,
"CRKL":1,
"HDAC inhibitor":1,
"MiR-200c":1,
"SAHA":2,
"childbearing":1,
"postpartum":1,
"pregnancy":2,
"dabrafenib":2,
"trametinib":2,
"undifferentiated":2,
"hyperthyroidism":4,
"radioiodine therapy":3,
"radioiodine thyroid uptake":1,
"reproducibility":1,
"aggressive behavior":1,
"hobnail variant":1,
"Invasion":7,
"Strap muscle":1,
"Voice":1,
"SDS":1,
"globus symptoms":1,
"quality of life":4,
"Follicular variant":4,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Proliferation":5,
"SNHG15":1,
"miR-211-3p":1,
"Combination anticancer chemotherapy":1,
"Energy metabolism":1,
"Glyoxalase I":1,
"Inhibitor":1,
"Pyruvate kinase M2":1,
"The Warburg effect":1,
"TROP2":1,
"Lymph node metastases":3,
"Microcarcinoma":1,
"Survival rate":2,
"cohort study":2,
"exercise treadmill test":1,
"heart rate recovery":1,
"NIFTP":8,
"follicular variant of papillary thyroid carcinoma":2,
"anaplastic thyroid carcinoma":8,
"follicular thyroid carcinoma":8,
"molecular pathology":2,
"poorly differentiated thyroid carcinoma":4,
"thyroid markers":1,
"thyroid tumours":1,
"familial medullary thyroid carcinoma":1,
"familial non-medullary thyroid carcinoma":1,
"familial thyroid carcinoma":1,
"multiple endocrine neoplasia":2,
"poorly differentiated":1,
"rare tumour":1,
"unusual tumour":1,
"Adrenocortical insufficiency":1,
"Adrenocorticotropic hormone":1,
"Cushing’s syndrome":1,
"Hyperaldosteronism, primary":1,
"Pheochromocytoma":3,
"BRAFV600E":2,
"Bortezomib":1,
"NF-κB":2,
"Vemurafenib":2,
"Aldehyde dehydrogenase":1,
"Cancer stem cells":1,
"Patient-derived xenograft tumor":1,
"Primary cells":1,
"Subpopulations of cancer stem cells":1,
"EZH2":1,
"epigenetics":1,
"prognostic factor":1,
"EMT":4,
"Tiam1":1,
"Wnt/β-catenin signaling":1,
"Pyruvate kinase":2,
"ovarian cancer":1,
"CT density change":1,
"head and neck cancer":5,
"radiation therapy":1,
"thyroid function":1,
"Inter-exam agreement":1,
"K-TIRADS":1,
"HuR":1,
"RNA-binding proteins":1,
"anaplastic thyroid cancer":5,
"siRNA":1,
"YAP":1,
"ZEB1":1,
"hTERT":1,
"Immune-related adverse events (irAEs)":1,
"Nivolumab":5,
"Non-small-cell lung cancer (NSCLC)":1,
"FTC":3,
"gene expression":2,
"minimally invasive":1,
"bone microenvironment":2,
"bone tropism":1,
"molecular mechanisms":1,
"therapeutic strategies":1,
"Chronic lymphocytic thyroiditis":2,
"C1QL1":1,
"CILP":1,
"CRABP1":1,
"LCN2":1,
"RNA sequencing":1,
"TCGA":1,
"3D–printed titanium sternum":1,
"Sternal tumor":1,
"Sternectomy":1,
"Aggressive features":1,
"Expression":1,
"PTC":2,
"VHL":1,
"miR-92a":1,
"cell proliferation":3,
"isoenzyme":1,
"lapatinib":1,
"Bone metastasis":1,
"IL-11":1,
"miR-124":1,
"Age-related cancer risk":1,
"Histologic features":1,
"Metastatic diffusion":1,
"Phenotypical expression":1,
"Thyroid cancer presentation":1,
"autoimmune":1,
"fulminant type 1 diabetes mellitus":1,
"immune checkpoint inhibitor":1,
"painless thyroiditis":1,
"WGCNA":1,
"competing endogenous RNA":1,
"differentially expressed RNAs":1,
"long non-coding RNA":1,
"regulatory network":1,
"FNA":4,
"Fine needle aspiration":2,
"Follow-up":2,
"Intervention":1,
"Nodule":1,
"Prospective study":1,
"Radiofrequency ablation":2,
"Tumor":2,
"Benign thyroid nodule":1,
"Laser":2,
"Laser ablation":1,
"Graves’ disease":2,
"aloperine":1,
"apoptosis":8,
"Cancer registry":2,
"China":1,
"Incidence":8,
"Malignant tumor":1,
"Mortality":9,
"cirrhosis":1,
"drugs and medicines":1,
"immunology":1,
"radiology":1,
"Body mass index":2,
"Central obesity":1,
"Overweight":1,
"Waist circumference":1,
"IgG4-related disease":1,
"Mass-forming thyroiditis":1,
"Regional lymphadenopathy":1,
"brain metastases":1,
"disease outcome":1,
"distant metastases":2,
"non-medullary":1,
"angiopoietin 1":1,
"angiopoietin receptor":1,
"phosphoinositide-3 kinase/RAC serine/threonine-protein kinase pathway":1,
"incidental findings":2,
"18 F-FDG-PET CT scan":1,
"Cystic neck lesion":1,
"FNAC":1,
"Squamous cell carcinoma":4,
"Therapeutics":1,
"Dose reduction":1,
"Hypertension":2,
"Targeted therapy":6,
"NCOA5":1,
"lymph node metastasis":10,
"Nasal cavity":1,
"stimulated serum thyroglobulin":1,
"unstimulated serum thyroglobulin":1,
"PRRT":1,
"mutations":3,
"peptide receptor radionuclide therapy":1,
"WW domain-containing transcription regulator protein 1":1,
"miR-144":1,
"papillary thyroid cancer":22,
"tumor sizes":1,
"Agarose cell block":1,
"HBME-1":1,
"fine-needle aspirate":1,
"galectin-3":2,
"thyroid tumors":2,
"advanced medullary thyroid carcinoma":1,
"apatinib":1,
"tyrosine kinase inhibitors":3,
"adrenal oncocytoma":1,
"concomitant neoplasia":1,
"functional adrenal neoplasm":1,
"hereditary cancer syndrome":1,
"Hepatitis B virus":1,
"Hepatitis C virus":1,
"Occupation":1,
"Parathyroid adenoma":1,
"Parathyroids":1,
"Shear wave elastography":4,
"sistrunk procedure":1,
"thyroglossal duct cyst":1,
"CD56":1,
"fine-needle aspiration cytology":1,
"immunocytochemistry":2,
"suspicion":1,
"PSMA":1,
"prostate cancer":1,
"tumor neoangiogenesis":1,
"RET":4,
"genetic instability":1,
"tumor clonality":1,
"cancer immunotherapy":1,
"granzyme A":1,
"immune cytolytic activity":1,
"perforin 1":1,
"tumor-associated neutrophils":1,
"tumor-infiltrating lymphocytes":1,
"Carcinoma thyroid":1,
"lymph node":5,
"matrix metalloproteinases":1,
"orbithopathy":1,
"tissue inhibitors of metalloproteinases":1,
"CST6":1,
"Cystatin E/M":1,
"Triple-negative breast cancer":1,
"progress":1,
"fine needle aspiration cystic fluid":1,
"proteome profiles":1,
"secretome":1,
"Meta-analysis":7,
"Positron emission tomography":2,
"Systematic review":1,
"Cowden syndrome":1,
"DICER1 syndrome":1,
"Hereditary":1,
"PTEN":2,
"Infarction after biopsi":1,
"synchronous tumor":1,
"thyroid papillary carcinoma":2,
"Histopathology":3,
"retrospective":1,
"thyroid diseases":1,
"ASPH":1,
"Invasive breast cancer":1,
"Methylation":2,
"Malignant pleural mesothelioma":1,
"antibody":1,
"calretinin, mesothelin":1,
"BISPR":1,
"Bcl-2":1,
"miR-21-5p":1,
"Graves´ disease":1,
"nuclear medicine":1,
"Complications":2,
"goiter":1,
"retrosternal goiter":2,
"ESCC":1,
"PKM2":1,
"glycolysis":2,
"mTOR":1,
"B-type Raf (BRAF)":1,
"Missed thyroid gland":1,
"substernal goiter":2,
"total thyroidectomy":4,
"hyalinizing trabecular tumor":1,
"trabecular pattern":1,
"KIT":1,
"PD-1":1,
"immune":2,
"radiotherapy":3,
"Complication":1,
"survival":11,
"I-131 therapy":1,
"management":1,
"pediatric cancer":1,
"thyroid caricinoma":1,
"Hyperspectral imaging":3,
"convolutional neural network":2,
"deep learning":2,
"head and neck surgery":2,
"intraoperative imaging":2,
"optical biopsy":1,
"Cavernous hemangioma":1,
"Ground-glass nodule":1,
"Solitary pulmonary capillary hemangioma":1,
"EG7":1,
"EL4":1,
"cyclophosphamide":1,
"immunotherapy":4,
"lymphoma":2,
"NRAS":2,
"miR-22":1,
"paclitaxel":1,
"tumor suppressor":2,
"ectopic meningioma":1,
"lung neoplasm":1,
"primary pulmonary meningioma":1,
"quality assurance":1,
"Central composite design":1,
"Chemometric tools":1,
"Metabolomics":1,
"Urine":1,
"Differential diagnosis":2,
"Large":1,
"Poor":1,
"circulating tumor cells (CTCs)":1,
"differentiated thyroid carcinoma (DTC)":1,
"minimally invasive follicular thyroid carcinoma (MIFC)":1,
"risk stratification":3,
"Duplex Doppler ultrasonography":1,
"Vascular resistance":1,
"BRAF":4,
"NTRK":1,
"dedifferentiated":1,
"sarcomatoid":1,
"squamous":1,
"Hürthle cell":1,
"Metabolism":1,
"glycine":1,
"serine":1,
"Laryngeal cancer":2,
"Laryngeal function preservation":1,
"Partial laryngectomy":1,
"Distant metastasis":2,
"Risk factor":3,
"Thick capsule":1,
"Tumor capsule":1,
"intravoxel incoherent motion":1,
"magnetic resonance imaging (MRI)":1,
"parotid gland":1,
"Sternotomy":1,
"DNA methylation profiling":1,
"Follicular adenoma":2,
"EPIC":1,
"fruit juices":1,
"fruits":1,
"intake":1,
"vegetables":1,
"Subependymoma":1,
"hemorrhage":1,
"multiplicity":1,
"ganglioneuromas":1,
"marfanoid":1,
"Cancer registries":1,
"Population-based":1,
"Spain":1,
"Robotic thyroidectomy":3,
"Transoral robotic thyroidectomy":1,
"Transoral thyroidectomy":3,
"30 mCi":2,
"50 mCi":1,
"Clinicopathological characteristics":1,
"Papillary thyroid microcarcinoma":1,
"Variant":2,
"Familial":1,
"HABP2":1,
"Nonmedullary thyroid cancer":1,
"Thailand":1,
"head and neck":3,
"nasopharyngeal cancer":1,
"oral cancer":1,
"oropharyngeal cancer":1,
"Calcium stimulation":1,
"Electrochemiluminescence immunoassay (ECLIA)":1,
"Male":2,
"Urinary iodine excretion":1,
"screening":3,
"Bile duct":1,
"Gallbladder cancer":1,
"3-dimensional ultrasound":1,
"contrast agents (clinical)":1,
"diagnostic efficiency":1,
"discrimination of malignant thyroid nodules":1,
"nodule-to-perinodule ratio":1,
"quantitative parameters of contrast-enhanced US time-intensity curve":1,
"receiver operating characteristic curve":1,
"statistics":1,
"DNA-based screening":1,
"RET proto-oncogene":3,
"biochemical screening":1,
"gene carrier":1,
"gene test":1,
"multiple endocrine neoplasia type 2A":2,
"cell apoptosis":1,
"cell cycle":3,
"gene silencing":1,
"hepatocellular carcinoma":2,
"features":1,
"surgeon":1,
"colorectal cancer":3,
"thyroid transcription factor-1":1,
"fine-needle aspiration":8,
"follicular neoplasm":2,
"thyroid cytology":2,
"Zenker's":1,
"diverticulum":1,
"MEN2":2,
"immunity":1,
"tumor stroma":1,
"Bayesian maximum entropy":1,
"Industrial density":1,
"Integrative disease predictability":1,
"Socioeconomic status":1,
"differentiated thyroid carcinoma":7,
"highly sensitive":1,
"immunoassay":1,
"thyroglobulin":5,
"major salivary gland carcinoma":1,
"population study":1,
"salivary gland carcinoma":1,
"second primary cancer":1,
"Wilms tumor":1,
"dosimetry":1,
"whole lung radiation":1,
"cytology":5,
"malignant pleural effusion":1,
"lateral neck metastases":1,
"neck levels":1,
"well-differentiated thyroid cancer":1,
"Growth":1,
"Periostin":1,
"TSHR":1,
"lung metastasis":1,
"Active disease":1,
"Disease-free":1,
"Interleukins":1,
"Endoscopic thyroidectomy":2,
"Natural orifice transluminal endoscopic surgery":1,
"clinical effect":1,
"molecular-targeted therapy":1,
"contralateral occult carcinoma":1,
"nondiagnostic":1,
"reporting":1,
"Immunoglobulin G4":1,
"Warthin-like variant":2,
"Non-coding RNA":1,
"Transcriptional control":1,
"Down syndrome":1,
"chronic conditions":1,
"late effects":2,
"leukemia":1,
"survivorship":1,
"pancreatic neoplasms":1,
"thyroid hormones":4,
"triiodothyronine":2,
"triple negative breast neoplasms":1,
"FDG-PET":2,
"Head and neck oncology":1,
"Melanoma":2,
"Oncologic imaging":1,
"PET/MR Imaging":1,
"PET/CT":2,
"choline":1,
"Nodular thyroid diseases":1,
"goitre":2,
"insulin resistance":2,
"metabolic syndrome":1,
"thyroid volume":1,
"MENX":1,
"p27 haploinsufficiency":1,
"gene fusion":1,
"genetic landscape":1,
"lncRNAs":2,
"oncogene":1,
"molecularly targeted therapy":1,
"state-of-the-art":1,
"tumor models":1,
"Breast neoplasm":1,
"Logistic model":1,
"Ultrasonographic pattern":1,
"atrial fibrillation":1,
"cardiovascular diseases":1,
"follow-up studies":2,
"iodine radioisotopes":2,
"atypia of undetermined significance or follicular lesion of undetermined significance":1,
"follicular neoplasm or Hürthle cell neoplasm":1,
"diagnostic imaging":1,
"ionizing radiation":3,
"review":1,
"Fine needle aspiration of the thyroid":1,
"dynamic risk stratification":1,
"pediatrics":2,
"treatment outcome":1,
"pediatric":1,
"atypia of undetermined significance/follicular lesion of undetermined significance":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"risk of malignancy":2,
"Doppler":1,
"noninvasive encapsulated follicular variant of papillary thyroid carcinoma":1,
"AKT3":1,
"TR4":1,
"clinical outcome":1,
"seminoma":1,
"Curcumin":2,
"EGCG, ATC":1,
"Genistein":1,
"Nutraceuticals":1,
"Resveratrol":3,
"Antigen retrieval":1,
"Hyalinizing trabecular tumour":1,
"Immunohistochemical staining":1,
"MIB-1":1,
"inferior laryngeal nerve":1,
"nonrecurrent laryngeal nerve":1,
"Childhood cancer/malignancy":1,
"Late/adverse effects":1,
"Surveillance":3,
"Survivors":1,
"Thyroid cancer/neoplasm":1,
"Multiple endocrine neoplasia 1":1,
"Primary hyperparathyroidism":2,
"Masaoka stage IVa":1,
"Anti-thyroglobulin antibody":1,
"Circulating epithelial cells":1,
"Potential biomarker":1,
"follicular thyroid cancer":2,
"immune checkpoint inhibitors":1,
"immunotherapies":1,
"ipilimumab":1,
"BRAF V600E mutation":1,
"Real time PCR":1,
"exercise":1,
"hormone replacement therapy":1,
"immune thrombocytopenia":1,
"lung cancer":3,
"ING5":1,
"Clinical experience":1,
"Differentiated thyroid cáncer":1,
"Iodine-refractory":1,
"Treatment costs":1,
"RET/PTC":1,
"medullary carcinoma":1,
"rearrangements":1,
"Alectinib (PubMed CID: 49806720)":1,
"Cabozantinib (PubMED CID: 25102847)":1,
"Catalytic spine":1,
"K/E/D/D":1,
"Lenvatinib (PubMED CID: 9823820)":1,
"Ponatinib (PubMED CID: 24826799":1,
"Protein kinase inhibitor classification":1,
"Protein kinase structure":1,
"Regulatory spine":1,
"Sorafenib (PubMED CID: 216239)":1,
"Sunitinib (PubMED CID: 5329102":1,
"Targeted cancer therapy":1,
"Vandetanib (PubMed CID: 3081361)":1,
"Dipeptidyl peptidase-IV":1,
"Gemigliptin":1,
"Metformin":1,
"Synergism":1,
"Quality of Life (QoL)":1,
"Bethesda V":1,
"cost analysis":1,
"frozen section":1,
"suspicious for malignancy":1,
"Hepatocellular carcinoma targeting":1,
"Lactoferrin":1,
"Liposomes":1,
"APC gene":1,
"promoter":1,
"autotransplantation":1,
"hypoparathyroidism":1,
"parathyroid gland":1,
"otter":1,
"pentastomiasis":1,
"tongue worm":1,
"Case–control study":1,
"Chernobyl fallout":1,
"Contaminated food":1,
"Dairy products":1,
"Leafy vegetables":1,
"antithyroglobulin antibodies":1,
"interference":1,
"Gastric cancer":5,
"Lymphocyte to monocyte ratio":1,
"Lateral compartment":1,
"genetic and molecular pathways":1,
"hyperplasia":1,
"multiple gland disease":1,
"sporadic primary hyperparathyroidism":1,
"PDT":1,
"Ras":1,
"Sulforaphene":1,
"MEN2A":1,
"Outcomes":2,
"Prophylactic thyroidectomy":1,
"Multifocal":1,
"CSN6":1,
"FH535":1,
"Wnt/β-catenin signaling pathway":1,
"Drosophila":1,
"multiple endocrine neoplasia type 2":2,
"zebrafish":1,
"National Health Insurance":1,
"dialysis":1,
"end-stage renal disease":1,
"Machine learning":1,
"Radiomics":1,
"Texture analysis":1,
"CCND2-AS1":1,
"LncRNA":2,
"Tumor staging":1,
"cytokeratin":1,
"esophageal cancer":1,
"lymph node micrometastasis":1,
"neoadjuvant chemoradiotherapy":1,
"randomized controlled trial":1,
"GOLPH3":1,
"nuclear inclusions":1,
"Acromegaly":2,
"Cushing syndrome":1,
"Hormones, ectopic":1,
"Inappropriate ADH syndrome":1,
"Positron emission tomography computed tomography":2,
"immuno-PET":2,
"thyroid FNA-cytology, tumor imaging in vivo":1,
"Gremlin1":1,
"Endoscopy":1,
"Postoperative complications":1,
"autophagy":2,
"pseudolaric acid B":1,
"Lobular breast cancer":1,
"Metastases to thyroid":1,
"Papillary cancer":1,
"Cervical cancer":1,
"Early diagnosis":1,
"Hematological malignancies":1,
"Long-term follow-up":1,
"Second malignancies":1,
"Stem-cell transplantation":1,
"Epithelial-mesenchymal transition":1,
"SNAI1":1,
"miR-199a-5p":1,
"Handling strategy":1,
"Reasonable":1,
"Laryngeal Recurrence":1,
"Transoral Laser Microsurgery":1,
"C reactive protein":1,
"DNA methylation":1,
"Folate intake":1,
"Folate metabolism":1,
"Inflammation":2,
"Central lymph node dissection":1,
"Clinical lymph node negative":1,
"Lateral lymph node dissection":1,
"Breast carcinoma in situ":1,
"SUV":1,
"Underestimation":1,
"cytokeratin-8":1,
"Suppurative thyroiditis":1,
"Thyroid abscess":1,
"Anti-oxidant":1,
"Nutraceutical":1,
"TPC-1 cells":1,
"Cancer progression":1,
"RRS1":1,
"Nonmedullary":1,
"True Familial":1,
"HMGB2":1,
"Warburg effect":2,
"hybrid imaging":1,
"SPECT/CT":1,
"miRNA-146a":1,
"microRNA":4,
"papillary thyroid carcinoma (PTC)":2,
"rs2910164":1,
"chemoprevention":1,
"thyroid tumorigenesis":1,
"TI-RADS":2,
"Gene networks":1,
"Gene set analysis":1,
"Modular organization":1,
"Node permutation":1,
"Random networks":1,
"Carcinoma of unknown primary":1,
"arterial dissections":1,
"cardiovascular":1,
"tyrosine-kinase inhibitors":1,
"Dual-specificity phosphatase 6":1,
"MAPK signaling":1,
"chemoresistance":1,
"chemoresponsiveness":1,
"CXCL12":1,
"CXCR4":1,
"CXCR7":1,
"oestrogen receptor-α":1,
"oestrogen receptor-β":1,
"Shanghai":1,
"temporal trend":1,
"medical occupational group":1,
"endocrine imaging":1,
"head and neck imaging":1,
"quantitative image analysis":1,
"sestamibi":1,
"solitary adenoma":1,
"computer-assisted":1,
"pattern recognition":1,
"Demons registration":1,
"digital histology":1,
"head and neck cancer surgery":1,
"cancer margin detection":1,
"local and pain control":1,
"radioresistant tumor":1,
"spinal metastases":1,
"spine SBRT":1,
"Neuroendocrine markers":1,
"TTF1":1,
"p40":1,
"DWI":1,
"DWI of solid parathyroid lesions":1,
"MRI":2,
"MRI findings solid parathyroid lesions":1,
"Solid parathyroid lesions":1,
"ROS":1,
"mesenchymal epithelial transition":1,
"nonsmall cell lung carcinoma":1,
"Autofluorescence":1,
"Near infrared":1,
"Epithelial–mesenchymal transition":1,
"Metastatic lymph nodes":1,
"Snail switch":1,
"Iodine":2,
"Câncer diferenciado de tireoide":1,
"Differentiated thyroid cancers":2,
"Disease free survival":1,
"Overall survival":1,
"Sobrevida global":1,
"Sobrevida livre de doença":1,
"Índice de massa corporal":1,
"Clinical trials":1,
"Equipoise":1,
"Ethics":1,
"Non-intervention":1,
"Research ethics":1,
"High-risk":1,
"Low-risk":1,
"De-escalation":2,
"Guidelines":1,
"Well-differentiated thyroid carcinoma":1,
"ACTH = adrenocorticotropic hormone":1,
"CSDH = chronic subdural hematoma":1,
"DI = diabetes insipidus":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"GTR = gross-total resection":1,
"ICA = internal carotid artery":1,
"LH = luteinizing hormone":1,
"NFPA = nonfunctional pituitary adenoma":1,
"NTR = near-total resection":1,
"SKA = supraorbital keyhole approach":1,
"TCA = transcranial approach":1,
"TSA = transsphenoidal approach":1,
"TSH = thyroid-stimulating hormone":1,
"combined approach":1,
"craniopharyngioma":2,
"eSKA = endoscopic SKA":1,
"eTSA = endoscopic TSA":1,
"keyhole":1,
"pituitary adenoma":2,
"supraorbital approach":1,
"transsphenoidal approach":1,
"Medullary":2,
"Parafollicular C-cells":1,
"Thyroglossal":1,
"ATA Guidelines":1,
"Radioactive iodine":1,
"Micro-papillary thyroid cancer":1,
"Multifocal papillary":1,
"Recurrence free survival":1,
"Tumor recurrence":1,
"Juvenile polyposis syndrome":1,
"Extensive vascular invasion":1,
"Hurthle cell carcinoma":1,
"non-diagnostic":1,
"High intensity focused ultrasound (HIFU)":1,
"SOX11":1,
"in vivo experiments":1,
"miR-211-5p":1,
"thyroid cancer (TC)":1,
"Metastatic thyroid carcinoma":1,
"Molecular signatures of thyroid carcinoma":1,
"Synchronous thyroid carcinomas":1,
"Cost-effectiveness":1,
"Palladia":1,
"canine":1,
"carboplatin":1,
"dogs":1,
"phase I":1,
"toceranib phosphate":1,
"Age":1,
"Ethnic background":1,
"Extrathyroid extension":1,
"Grade":1,
"Prognostic markers":1,
"Radioactive iodine avidity":1,
"Size":1,
"Stratification":1,
"CME":1,
"Colon cancer":2,
"Complete mesocolic excision":1,
"Laparoscopy":1,
"Mesofascial separation":1,
"sonography":1,
"thymus":1,
"Case-control study":1,
"Haplogroup K":1,
"mtDNA haplogroups":1,
"Combined technique":1,
"Lymphoscintigraphy":1,
"Patent blue injection":1,
"Sentinel lymph node":1,
"Autoimmune thyroiditis":1,
"Normoechogenic thyroid background":1,
"Normoechogenic thyroid parenchyma":1,
"aTG":1,
"aTPO":1,
"fine-needle cytologic examination":1,
"High intensity focused ultrasound":1,
"Microwave ablation":1,
"driver mutations":1,
"psammoma bodies":1,
"ultrasound techniques/physics":1,
"BRAF V600E":1,
"RAS mutations":2,
"Behçet disease":1,
"hazard ratio":1,
"myeloid neoplasm radioactive treatment":1,
"Thyroid Imaging Reporting and Data System":1,
"Virtual Touch tissue imaging quantification":1,
"Prophylactic surgical procedures":1,
"Risk assessment":1,
"EIF1AX":1,
"Hürthle cell carcinoma":2,
"TP53":1,
"Central Neck Dissection":1,
"Adjuvant endocrine therapy":1,
"Leuprorelin acetate":1,
"Luteinizing hormone-releasing hormone agonist":1,
"Premenopausal endocrine-responsive breast cancer":1,
"anterolateral thigh (ALT) flap":1,
"esophagus and voice reconstruction":1,
"free ileocolon flap":1,
"total pharyngolaryngectomy":1,
"saliva":1,
"xerostomia":2,
"CT":1,
"PET":1,
"findings":1,
"imaging":2,
"incidental":1,
"Histologic mimics":1,
"Metastatic neoplasms":1,
"Microscopic simulants of metastasis":1,
"anxiety":1,
"clinical guidelines":1,
"interdisciplinary care":1,
"screening for distress":1,
"symptom management":1,
"Asymptomatic":1,
"Symptomatic":1,
"MET proto-oncogene":1,
"familial medullary thyroid cancer":1,
"whole exome sequencing":2,
"HRPT2/CDC73":1,
"hyperparathyroidism-jaw tumor syndrome":1,
"younger age":1,
"Intramedullary metastasis":1,
"Spinal cord tumour":1,
"accuracy":2,
"indeterminate thyroid cytology":1,
"molecular diagnostics":1,
"cytological finding":1,
"familial thyroid cancer":1,
"family history":1,
"thyroid disease":4,
"artificial intelligence":1,
"artificial neural network":1,
"carbon dioxide embolism":1,
"remote access thyroidectomy":1,
"PTEN hamartoma tumor syndrome (PHTS)":1,
"Adolescents":1,
"Adults":1,
"Childhood cancer survivors":1,
"mitogen-activated protein kinase pathway":1,
"solute carrier family 35 member F2":1,
"tumorigenesis":2,
"Adequacy":1,
"Liquid-based cytology":1,
"Needle gauge":1,
"molecular testing":2,
"Cancer stem-like cells":1,
"Epithelial to mesenchymal transition":1,
"In situ hybridization":1,
"Long non-coding RNAs":1,
"Diffuse uptake":1,
"Focal uptake":1,
"Branchial cleft cyst":1,
"Lateral neck":1,
"Squamous cell carcinoma (SCC)":1,
"renal cell carcinoma":1,
"H19":1,
"Long noncoding RNA":1,
"treatment protocol":1,
"cosmetic effect":1,
"transoral endoscopic thyroidectomy":1,
"circulating miRNA":1,
"miR-375":1,
"prognostic biomarker":1,
"Strain value":1,
"TIRADS":1,
"Thyroid ultrasound":1,
"Visual elasticity scores":1,
"CDK4":1,
"CDK6":1,
"LEE011":1,
"Retinoblastoma protein (RB)":1,
"ASCT2":1,
"boramino acid":1,
"cancer imaging":1,
"Intracranial metastases":1,
"Neurosurgery":1,
"Whole brain radiotherapy":1,
"angiogenesis":3,
"miRNA-205":1,
"TRAIL resistance":1,
"cIAP1/2":1,
"GAS8-AS1":1,
"DICER1":1,
"endocrine tumors":1,
"neoplasms":1,
"AFAP1-AS1":1,
"Cell growth":1,
"Migration":1,
"precancerous conditions":1,
"Japan":1,
"liquid biopsy":1,
"peripheral blood":1,
"lateral cervical lymph node metastasis":1,
"sporadic medullary thyroid carcinoma":1,
"progression-free survival":1,
"radioactive iodine refractory":1,
"real-world clinical practice":1,
"sorafenib":1,
"GEC testing":1,
"Indeterminate FNAB":1,
"gene fusions and mutations":1,
"Copper-64":1,
"Platelet-derived growth factor receptor":1,
"calcium deposition":1,
"hyalinized trabecular tumor":1,
"thyroid tumor":1,
"von Kossa stain":1,
"endocrine neoplasm":1,
"IDO1":1,
"Immune checkpoint":1,
"Immuno-oncology":1,
"Indoleamine 2,3-dioxygenase 1":1,
"PD-L1":1,
"PD1":1,
"Programmed cell death ligand 1":2,
"SEER":3,
"tumor size":1,
"Aggressive variants":1,
"Autoimmunity":1,
"Thyrotrophin":1,
"biomarkers":1,
"encapsulated PTC":1,
"follicular variant of PTC":1,
"miRNA":1,
"circulation tumor cells":1,
"Sanger sequencing":2,
"informative marker":1,
"preimplantation genetic diagnosis":1,
"targeted sequencing":1,
"Desmoplasia":1,
"Node":1,
"Fine needle aspiration (FNA)":1,
"Indeterminate follicular proliferation":1,
"Extranodal extension":1,
"Lymph node size":1,
"Size stratification":1,
"DNA repair":1,
"radiosensitivity":1,
"thyroid cells":1,
"presentation":1,
"treatment":1,
"trends":1,
"Treatment de-escalation":1,
"EPR effect":1,
"HPMA":1,
"Iodine-131":1,
"RAFT":1,
"Walker 256 mammary carcinoma":1,
"RAI-resistant":1,
"Recurrence risk":1,
"TERT promoter mutations":1,
"ETV6/NTRK3":1,
"gene alteration":1,
"sporadic":1,
"Dose-volume parameters":1,
"HNSCC":1,
"Radiation-induced HT":1,
"TSH":3,
"Biopsy, fine-needle":1,
"Hashimoto disease":1,
"Thyroid cancer, papillary":1,
"Squamous differentiation":1,
"Carcinoma de células de Hürthle":1,
"Carcinoma folicular de tiroides":1,
"Disease-free survival":1,
"Supervivencia libre de enfermedad":1,
"Tiroidectomía":1,
"B-Raf proto-oncogene":1,
"molecular biology":1,
"rat sarcoma":1,
"serine/threonine kinase":1,
"telomerase reverse transcriptase promoter":1,
"BRCA1":1,
"BRCA2":1,
"Chinese population":1,
"clinic-pathological":1,
"BTG2":1,
"PRMT5":1,
"Prognostic marker":1,
"body weight":1,
"endocrine surgery":1,
"general surgery":1,
"prognostic significance":1,
"Adenocarcinoma":1,
"Bone neoplasm":1,
"Follicular":1,
"Cancer thyroïdien":1,
"Goitre ovarien":1,
"Ovarian teratoma":1,
"Struma ovarii":1,
"Tératome ovarien":1,
"T cytotoxic 17":1,
"T helper 17 cells":1,
"radioactive iodine-131":1,
"regulatory T cells":1,
"Organoid":1,
"Thyroid cancer model":1,
"p53":1,
"salivary hypofunction":1,
"Histology":1,
"Low-grade malignant endolymphatic sac tumor":1,
"VHL syndrome":1,
"TNM staging":1,
"Communication":1,
"Decision making":1,
"Overdiagnosis":1,
"Overtreatment":1,
"Treatment preferences":1,
"Coarse calcification":1,
"Computed tomography histogram":1,
"Race":1,
"medications":1,
"oral lichen planus":1,
"oral lichenoid drug reaction":1,
"oral lichenoid lesion":1,
"systemic disease":1,
"Predictive model":1,
"Eudorcas thomsonii":1,
"Thomson's gazelle":1,
"thyroid transcription factor":1,
"FDG PET/CT":1,
"Fluorine-18-fluorodeoxyglucose":1,
"Metabolic tumor volume":1,
"Thyroid incidentaloma":1,
"Total lesion glycolysis":1,
"South Korea":1,
"detection bias":1,
"nuclear power plant":1,
"Extra-pulmonary malignancy":1,
"Interventional bronchoscopy":1,
"Malignant central airway obstruction":1,
"ICCC":1,
"age-standardized incidence rate":1,
"annual percent change":1,
"childhood cancer":1,
"evidence synthesis":1,
"indirect treatment comparison":1,
"number needed to treat":1,
"Activating mutation":1,
"Fibrous dysplasia":1,
"GNAS":1,
"Heterotrimeric Gs protein":1,
"Intraductal papillary mucinous neoplasm":1,
"McCune Albright Syndrome":1,
"Over diagnosis":1,
"PTMC":1,
"Pathological classifications":1,
"Radiation":2,
"immune-related adverse event":1,
"myositis":1,
"Angioinvasive FTC":1,
"Developing country":1,
"Minimally invasive FTC":1,
"Widely invasive FTC":1,
"Hypopharynx":1,
"Larynx":1,
"Lymphnode":1,
"Small-sized thyroid carcinoma":1,
"Metastatic FTC":1,
"Occult primary malignancy":1,
"Occult thyroid carcinoma":1,
"IL13Rα2 siRNA":1,
"columnar cell":1,
"disease-specific survival":1,
"encapsulated variant":1,
"external beam radiotherapy":1,
"Thyroid cancer and age":1,
"Thyroid cancer staging":1,
"post-operative scar":1,
"scar":1,
"lymph node aspirate for thyroglobulin (LN-FNA-Tg)":1,
"malignant sonographic features of lymph nodes":1,
"Central cervical lymph node":1,
"Neoplasms metastasis, lymph node":1,
"Ultrasound examination":1,
"Waddington landscape":1,
"developmental history":1,
"non-small cell lung cancers":1,
"transdifferentiation":1,
"tumor heterogeneity":1,
"tumor plasticity":1,
"Myxoid liposarcoma":1,
"mucinous carcinoma":1,
"primary thyroid cancer":1,
"signet-ring-cell differentiation":1,
"8505c cells":1,
"Baicalein":1,
"Combination therapy":1,
"Docetaxel":1,
"Thyroid carcinoma, anaplastic":1,
"adrenal disorders":1,
"endocrine cancer":1,
"Disease persistence":1,
"CRABP2":1,
"drug resistance":1,
"retinoic acid":1,
"Long noncoding RNAs (lncRNAs)":1,
"Papillary thyroid cancer (PTC)":1,
"breast tumours":1,
"preventive medicine":1,
"Immunohistochemical expression":1,
"Macrophages":1,
"TGF-β pathway":1,
"interferon γ":1,
"interleukin 21":1,
"circulating cell-free DNA":1,
"2018":1,
"ACTH":1,
"Adult":1,
"Breathing difficulties":1,
"CT scan":1,
"Desmopressin":1,
"Diabetes insipidus":1,
"Face - coarse features":1,
"Fatigue":1,
"Fine needle aspiration biopsy":1,
"GH":1,
"GH suppression":1,
"Glucocorticoids":1,
"Glucose tolerance (oral)":1,
"Gonadotrophins":1,
"Gonadotropins":1,
"Hands - enlargement":1,
"Headache":1,
"Hydrocortisone":1,
"Hypergonadotropic hypogonadism":1,
"Hypogonadism":1,
"IGF1":1,
"Lanreotide":1,
"Levothyroxine":1,
"March":1,
"PET scan":1,
"Pituitary":1,
"Prolactin":1,
"Resection of tumour":1,
"Somatostatin analogues":1,
"Synaptophysin":1,
"Testosterone":1,
"Transsphenoidal surgery":1,
"Unique/unexpected symptoms or presentations of a disease":1,
"United Kingdom":1,
"Vision - acuity reduction":1,
"Visual field assessment":1,
"Visual impairment":1,
"White":1,
"X-ray":1,
"Multiple primary neoplasms":1,
"AMP kinase":1,
"glutaminolysis":1,
"hexokinase":1,
"hypoxia-inducible factor":1,
"mammalian target of rapamycin protein":1,
"18F-FDG PET/CT":1,
"99mTc-MIBI":1,
"sclerosing pneumocytoma":1,
"Airway stents":1,
"airway obstruction/therapy":1,
"bronchi/pathology":1,
"prosthesis design":1,
"prosthesis implantation":1,
"tracheal neoplasms/therapy":1,
"PDX":1,
"hypoxia":1,
"photoacoustic imaging":1,
"endometriosis associated ovarian carcinoma":1,
"ovarian endometriosis":1,
"prediction of malignant transformation":1,
"different diseases":1,
"sensitivity":1,
"sonoelastography":1,
"specificity":1,
"TIPE":1,
"TNF-α":1,
"TNFAIP8":1,
"Cali":1,
"Colombia":1,
"methods":1,
"Ecuador":1,
"Latin America":1,
"Bucaramanga":1,
"records as subject":1,
"deferred intervention":1,
"low risk thyroid cancer":1,
"thyroid lobectomy":1,
"Thyroid metastasis":1,
"tonsil squamous cell carcinoma":1,
"HOXC6":1,
"Linc00339":1,
"MiR-377-3p":1,
"progression":1,
"triple-negative breast cancer (TNBC)":1,
"Mitochondrial targeting":1,
"TPA":1,
"TR3":1,
"FVPTC":1,
"AUS":1,
"Bethesda classification":1,
"FLUS":1,
"Indeterminate":1,
"glucose metabolism":1,
"healthspan":1,
"lifespan":1,
"Mena":1,
"overexpression":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年第1季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
